Trump will hold meeting on vaping

Amy Baxter | | Health Exec | Policy & Regulations

President Trump plans to hold a meeting with officials from the e-cigarette industry and medical field amid an epidemic of vaping-related illnesses and deaths, The Wall Street Journal reported.

Trump previously announced a plan to ban non-tobacco flavored e-cigarette products in September over the epidemic of vaping injuries. As of Nov. 8, more than 2,000 people have been diagnosed with the illness, e-cigarette, or vaping, product use associated lung injury (EVALI), and 39 deaths have been reported.

However, Trump walked back on its planned ban, according to recent November reports. The administration also made an exception for menthol flavors in its plan.

The meeting with officials will include a group of advocacy, industry, non-profits, medical associations and state officials, the WSJ reported. Among the policy considerations is raising the minimum purchasing age from 18 to 21, which is supported by e-cigarette company Juul.

See the full story below:

Trump to Convene Meeting on Vaping

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

Q&A: Vulnerable patients hit hardest by anesthesia reimbursement cuts
Momentum continues for renal denervation as CMS considers national Medicare coverage
4 ways HHS plans to help shape a national strategy for healthcare AI
Johnson & Johnson buys depression drug and its manufacturer for $15B
FDA announces recall after Philips heart monitor software failed to send alerts—multiple deaths reported
Why electrophysiologists needed a champion in Washington

Around the web

AI in Healthcare
4 ways HHS plans to help shape a national strategy for healthcare AI

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.

Cardiovascular Business
FDA announces recall after Philips heart monitor software failed to send alerts—multiple deaths reported

Philips is recalling the software associated with its Mobile Cardiac Outpatient Telemetry devices after certain high-risk ECG events were never routed to trained cardiology technicians as intended. The issue, which lasted for two years, has been linked to more than 100 injuries. 

Cardiovascular Business
Why electrophysiologists needed a champion in Washington

Heart Rhythm Society President Kenneth A. Ellenbogen, MD, detailed a new advocacy group focused on improving EP reimbursements, patient care and access. “If you’re not at the table, you’re on the menu," he said.